NCT01314755View on ClinicalTrials.gov

A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Squamous Cell Carcinoma of MouthSquamous Cell Carcinoma of OropharynxLaryngeal Squamous Cell CarcinomaSquamous Cell Carcinoma of the Hypopharynx
Interventions
DIETARY_SUPPLEMENT

IMPACT

IMPACT (Nestlé Healthcare Nutrition, Minnetonka, MN, USA) an 'immune-enhancing' feed which contains supplemental L-arginine (1.25 78 g/L), dietary nucleotides (1.2 g/L) and omega-3 fatty acids in the form of 79 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (EPA/DHA 1.7 g/L) 80 as its active ingredients.

DIETARY_SUPPLEMENT

An iso-caloric, iso-nitrogenous control feed

Trial Locations (1)

L9 7AL

University Hospital Aintree, Liverpool

All Listed Sponsors
collaborator

Société des Produits Nestlé (SPN)

INDUSTRY

lead

Terrence Jones

OTHER_GOV

NCT01314755 - A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck Cancer | Biotech Hunter | Biotech Hunter